70/100B101.820
USD
-3.03
(-2.89%)
Pre Open
Last updated: · Delayed 15 min
Fair value103.28Plus-1%77Price 101.82180
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
Medtronic revenue 1986–2027What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
Medtronic's revenue in Q1 FY2027, the three months to 31 July 2026, was 9.76B USD, up 13.7% on the same quarter a year before. Medtronic's revenue over the last twelve months was 37.54B USD, up 9.8% on the twelve months before. In fiscal year 2026 it was 36.36B USD, up 8.4% on the year before.
Last updated 6 Nov 2026 · Next report 24 Nov 2026
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 31 Jul 2026 | 37.54B | +9.77% | 25.04B | 5.23B |
| FY2026 | 24 Apr 2026 | 36.36B | +8.43% | 23.64B | 4.80B |
| FY2025 | 25 Apr 2025 | 33.54B | +3.62% | 21.91B | 4.66B |
| FY2024 | 26 Apr 2024 | 32.36B | +3.64% | 21.15B | 3.68B |
| FY2023 | 28 Apr 2023 | 31.23B | -1.45% | 20.51B | 3.76B |
| FY2022 | 29 Apr 2022 | 31.69B | +5.21% | 21.54B | 5.04B |
| FY2021 | 30 Apr 2021 | 30.12B | +4.16% | 19.63B | 3.61B |
| FY2020 | 30 Apr 2020 | 28.91B | -5.38% | 19.49B | 4.79B |
| FY2019 | 26 Apr 2019 | 30.56B | +2.02% | 21.40B | 4.63B |
| FY2018 | 27 Apr 2018 | 29.95B | +0.82% | 20.89B | 3.10B |
| FY2017 | 28 Apr 2017 | 29.71B | +3.04% | 20.42B | 4.03B |
| FY2016 | 29 Apr 2016 | 28.83B | +42.31% | 19.69B | 3.54B |
| FY2015 | 30 Apr 2015 | 20.26B | +19.15% | 13.95B | 2.68B |
| FY2014 | 25 Apr 2014 | 17.01B | +2.50% | 12.67B | 3.07B |
| FY2013 | 30 Apr 2013 | 16.59B | +2.51% | 12.46B | 3.47B |
| FY2012 | 30 Apr 2012 | 16.18B | +1.58% | 12.30B | 3.62B |
| FY2011 | 30 Apr 2011 | 15.93B | +0.73% | 11.81B | 3.10B |
| FY2010 | 30 Apr 2010 | 15.82B | +8.34% | 11.81B | 3.10B |
| FY2009 | 30 Apr 2009 | 14.60B | +8.02% | 11.08B | 2.17B |
| FY2008 | 30 Apr 2008 | 13.52B | +9.89% | 10.07B | 2.23B |
| FY2007 | 30 Apr 2007 | 12.30B | +8.92% | 9.13B | 2.80B |
| FY2006 | 30 Apr 2006 | 11.29B | +12.31% | 8.48B | 2.55B |
| FY2005 | 30 Apr 2005 | 10.05B | +10.65% | 7.61B | 1.80B |
| FY2004 | 30 Apr 2004 | 9.09B | +18.55% | 6.83B | 1.96B |
| FY2003 | 30 Apr 2003 | 7.67B | +19.57% | 5.77B | 1.60B |
| FY2002 | 30 Apr 2002 | 6.41B | +15.47% | 4.76B | 984.00M |
| FY2001 | 30 Apr 2001 | 5.55B | +10.71% | 4.44B | 1.05B |
| FY2000 | 30 Apr 2000 | 5.01B | +21.30% | 3.99B | 1.10B |
| FY1999 | 30 Apr 1999 | 4.13B | +58.71% | 3.35B | 468.40M |
| FY1998 | 30 Apr 1998 | 2.60B | +6.83% | 2.68B | 594.60M |
| FY1997 | 30 Apr 1997 | 2.44B | +12.41% | 2.32B | 583.20M |
| FY1996 | 30 Apr 1996 | 2.17B | +24.49% | 1.69B | 428.30M |
| FY1995 | 30 Apr 1995 | 1.74B | +25.27% | 1.31B | 294.00M |
| FY1994 | 30 Apr 1994 | 1.39B | +4.72% | 1.04B | 232.40M |
| FY1993 | 30 Apr 1993 | 1.33B | +12.86% | 977.70M | 197.20M |
| FY1992 | 30 Apr 1992 | 1.18B | +15.22% | 854.50M | 161.50M |
| FY1991 | 30 Apr 1991 | 1.02B | +22.09% | 736.20M | 133.40M |
| FY1990 | 30 Apr 1990 | 836.60M | +12.79% | 604.20M | 108.70M |
| FY1989 | 30 Apr 1989 | 741.70M | +13.53% | 547.30M | 97.40M |
| FY1988 | 30 Apr 1988 | 653.30M | +30.14% | 472.30M | 86.50M |
| FY1987 | 30 Apr 1987 | 502.00M | +24.63% | 359.20M | 73.80M |
| FY1986 | 30 Apr 1986 | 402.80M | — | 285.30M | 53.40M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q1 FY2027 | 31 Jul 2026 | 9.76B | +13.73% | 6.34B | 1.47B |
| Q4 FY2026 | 30 Apr 2026 | 9.81B | +9.86% | 7.44B | 1.24B |
| Q3 FY2026 | 31 Jan 2026 | 9.02B | +8.76% | 5.85B | 1.14B |
| Q2 FY2026 | 31 Oct 2025 | 8.96B | +6.64% | 5.41B | 1.37B |
| Q1 FY2026 | 31 Jul 2025 | 8.58B | +8.38% | 4.95B | 1.04B |
| Q4 FY2025 | 25 Apr 2025 | 8.93B | +3.94% | 5.78B | 1.06B |
| Q3 FY2025 | 31 Jan 2025 | 8.29B | +2.51% | 5.51B | 1.29B |
| Q2 FY2025 | 31 Oct 2024 | 8.40B | +5.25% | 5.46B | 1.27B |
| Q1 FY2025 | 26 Jul 2024 | 7.92B | +2.77% | 5.15B | 1.04B |
| Q4 FY2024 | 26 Apr 2024 | 8.59B | +0.53% | 5.55B | 654.00M |
| Q3 FY2024 | 26 Jan 2024 | 8.09B | +4.68% | 5.31B | 1.32B |
| Q2 FY2024 | 27 Oct 2023 | 7.98B | +5.26% | 5.22B | 909.00M |
| Q1 FY2024 | 28 Jul 2023 | 7.70B | +4.49% | 5.07B | 791.00M |
| Q4 FY2023 | 28 Apr 2023 | 8.54B | +5.62% | 5.57B | 1.18B |
| Q3 FY2023 | 27 Jan 2023 | 7.73B | -0.46% | 5.04B | 1.22B |
| Q2 FY2023 | 28 Oct 2022 | 7.59B | -3.34% | 5.05B | 427.00M |
| Q1 FY2023 | 29 Jul 2022 | 7.37B | -7.71% | 4.86B | 929.00M |
| Q4 FY2022 | 29 Apr 2022 | 8.09B | -1.21% | 5.50B | 1.49B |
| Q3 FY2022 | 28 Jan 2022 | 7.76B | -0.15% | 5.30B | 1.48B |
| Q2 FY2022 | 29 Oct 2021 | 7.85B | +2.62% | 5.35B | 1.31B |
| Q1 FY2022 | 30 Jul 2021 | 7.99B | +22.74% | 5.39B | 763.00M |
| Q4 FY2021 | 30 Apr 2021 | 8.19B | +36.51% | 5.54B | 1.36B |
| Q3 FY2021 | 29 Jan 2021 | 7.78B | +0.75% | 5.15B | 1.27B |
| Q2 FY2021 | 30 Oct 2020 | 7.65B | -0.77% | 4.94B | 489.00M |
| Q1 FY2021 | 31 Jul 2020 | 6.51B | -13.16% | 4.00B | 487.00M |
| Q4 FY2020 | 30 Apr 2020 | 6.00B | -26.37% | 3.73B | 646.00M |
| Q3 FY2020 | 31 Jan 2020 | 7.72B | +2.27% | 5.32B | 1.92B |
| Q2 FY2020 | 31 Oct 2019 | 7.71B | +3.01% | 5.31B | 1.36B |
| Q1 FY2020 | 26 Jul 2019 | 7.49B | +1.48% | 5.13B | 864.00M |
| Q4 FY2019 | 26 Apr 2019 | 8.15B | +0.02% | 5.66B | 1.17B |
| Q3 FY2019 | 31 Jan 2019 | 7.55B | +2.40% | 5.28B | 1.27B |
| Q2 FY2019 | 26 Oct 2018 | 7.48B | +6.11% | 5.28B | 1.12B |
| Q1 FY2019 | 27 Jul 2018 | 7.38B | -0.08% | 5.18B | 1.08B |
| Q4 FY2018 | 27 Apr 2018 | 8.14B | +2.88% | 5.75B | 1.46B |
| Q3 FY2018 | 26 Jan 2018 | 7.37B | +1.18% | 5.18B | -1.39B |
| Q2 FY2018 | 27 Oct 2017 | 7.05B | -4.02% | 4.93B | 2.02B |
| Q1 FY2018 | 28 Jul 2017 | 7.39B | +3.13% | 5.04B | 1.02B |
| Q4 FY2017 | 28 Apr 2017 | 7.92B | +4.61% | 5.48B | 1.16B |
| Q3 FY2017 | 27 Jan 2017 | 7.28B | +5.03% | 5.02B | 821.00M |
| Q2 FY2017 | 28 Oct 2016 | 7.35B | +4.07% | 5.02B | 1.12B |
| Q1 FY2017 | 29 Jul 2016 | 7.17B | -1.48% | 4.91B | 929.00M |
| Q4 FY2016 | 29 Apr 2016 | 7.57B | +3.60% | 5.20B | 1.10B |
| Q3 FY2016 | 29 Jan 2016 | 6.93B | +60.58% | 4.79B | 1.10B |
| Q2 FY2016 | 30 Oct 2015 | 7.06B | +61.66% | 4.88B | 520.00M |
| Q1 FY2016 | 31 Jul 2015 | 7.27B | +70.23% | 4.82B | 820.00M |
| Q4 FY2015 | 30 Apr 2015 | 7.30B | +59.96% | 4.37B | -1.00M |
| Q3 FY2015 | 31 Jan 2015 | 4.32B | +3.72% | 3.19B | 977.00M |
| Q2 FY2015 | 31 Oct 2014 | 4.37B | +4.10% | 3.22B | 828.00M |
| Q1 FY2015 | 31 Jul 2014 | 4.27B | +4.65% | 3.17B | 871.00M |
| Q4 FY2014 | 30 Apr 2014 | 4.57B | +2.40% | 3.39B | 448.00M |
| Q3 FY2014 | 31 Jan 2014 | 4.16B | +3.38% | 3.11B | 762.00M |
| Q2 FY2014 | 31 Oct 2013 | 4.19B | +2.42% | 3.10B | 902.00M |
| Q1 FY2014 | 31 Jul 2013 | 4.08B | +1.87% | 3.06B | 953.00M |
| Q4 FY2013 | 30 Apr 2013 | 4.46B | +3.77% | 3.33B | 969.00M |
| Q3 FY2013 | 31 Jan 2013 | 4.03B | +2.78% | 3.03B | 988.00M |
| Q2 FY2013 | 31 Oct 2012 | 4.10B | -0.90% | 3.08B | 646.00M |
| Q1 FY2013 | 31 Jul 2012 | 4.01B | -1.01% | 3.04B | 864.00M |
| Q4 FY2012 | 30 Apr 2012 | 4.30B | +0.05% | 3.25B | 991.00M |
| Q3 FY2012 | 31 Jan 2012 | 3.92B | -1.09% | 2.99B | 935.00M |
| Q2 FY2012 | 31 Oct 2011 | 4.13B | +5.87% | 3.06B | 871.00M |
| Q1 FY2012 | 31 Jul 2011 | 4.05B | +7.32% | 3.00B | 821.00M |
| Q4 FY2011 | 30 Apr 2011 | 4.30B | +2.36% | 3.23B | 776.00M |
| Q3 FY2011 | 31 Jan 2011 | 3.96B | +2.86% | 2.92B | 924.00M |
| Q2 FY2011 | 31 Oct 2010 | 3.90B | +1.69% | 2.94B | 566.00M |
| Q1 FY2011 | 31 Jul 2010 | 3.77B | -4.07% | 2.88B | 830.00M |
| Q4 FY2010 | 30 Apr 2010 | 4.20B | +9.58% | 3.18B | 954.00M |
| Q3 FY2010 | 31 Jan 2010 | 3.85B | +10.22% | 2.94B | 831.00M |
| Q2 FY2010 | 31 Oct 2009 | 3.84B | +7.51% | 2.92B | 868.00M |
| Q1 FY2010 | 31 Jul 2009 | 3.93B | +6.13% | 2.97B | 445.00M |
| Q4 FY2009 | 30 Apr 2009 | 3.83B | -0.80% | 2.90B | 128.00M |
| Q3 FY2009 | 31 Jan 2009 | 3.49B | +2.61% | 2.65B | 698.00M |
| Q2 FY2009 | 31 Oct 2008 | 3.57B | +14.28% | 2.69B | 547.00M |
| Q1 FY2009 | 31 Jul 2008 | 3.71B | +18.52% | 2.85B | 723.00M |
| Q4 FY2008 | 30 Apr 2008 | 3.86B | +17.68% | 2.92B | 813.00M |
| Q3 FY2008 | 31 Jan 2008 | 3.41B | +11.71% | 2.54B | 77.00M |
| Q2 FY2008 | 31 Oct 2007 | 3.12B | +1.59% | 2.28B | 666.00M |
| Q1 FY2008 | 31 Jul 2007 | 3.13B | +7.94% | 2.34B | 675.00M |
| Q4 FY2007 | 30 Apr 2007 | 3.28B | +6.96% | 2.41B | 812.00M |
| Q3 FY2007 | 31 Jan 2007 | 3.05B | +10.06% | 2.27B | 710.00M |
| Q2 FY2007 | 31 Oct 2006 | 3.08B | +11.20% | 2.28B | 681.00M |
| Q1 FY2007 | 31 Jul 2006 | 2.90B | +7.68% | 2.17B | 599.00M |
| Q4 FY2006 | 30 Apr 2006 | 3.07B | +10.39% | 2.30B | 740.00M |
| Q3 FY2006 | 31 Jan 2006 | 2.77B | +9.44% | 2.07B | 669.60M |
| Q2 FY2006 | 31 Oct 2005 | 2.77B | +15.23% | 2.07B | 816.50M |
| Q1 FY2006 | 31 Jul 2005 | 2.69B | +14.68% | 2.04B | 320.60M |
| Q4 FY2005 | 30 Apr 2005 | 2.78B | +4.22% | 2.07B | 194.40M |
| Q3 FY2005 | 31 Jan 2005 | 2.53B | +15.36% | 1.93B | 544.10M |
| Q2 FY2005 | 31 Oct 2004 | 2.40B | +10.91% | 1.82B | 535.70M |
| Q1 FY2005 | 31 Jul 2004 | 2.35B | +13.66% | 1.80B | 529.70M |
| Q4 FY2004 | 30 Apr 2004 | 2.67B | +24.10% | 2.00B | 568.90M |
| Q3 FY2004 | 31 Jan 2004 | 2.19B | +14.71% | 1.66B | 463.90M |
| Q2 FY2004 | 31 Oct 2003 | 2.16B | +14.43% | 1.63B | 476.10M |
| Q1 FY2004 | 31 Jul 2003 | 2.06B | +20.44% | 1.55B | 450.40M |
| Q4 FY2003 | 30 Apr 2003 | 2.15B | +19.89% | 1.61B | 487.10M |
| Q3 FY2003 | 31 Jan 2003 | 1.91B | +20.10% | 1.44B | 427.70M |
| Q2 FY2003 | 31 Oct 2002 | 1.89B | +20.35% | 1.43B | 301.70M |
| Q1 FY2003 | 31 Jul 2002 | 1.71B | +17.74% | 1.30B | 383.30M |
| Q4 FY2002 | 30 Apr 2002 | 1.79B | +18.02% | 1.33B | 300.90M |
| Q3 FY2002 | 31 Jan 2002 | 1.59B | +16.95% | 1.18B | 314.90M |
| Q2 FY2002 | 31 Oct 2001 | 1.57B | +15.41% | 1.17B | 66.70M |
| Q1 FY2002 | 31 Jul 2001 | 1.46B | +11.13% | 1.08B | 301.50M |
| Q4 FY2001 | 30 Apr 2001 | 1.52B | +5.98% | 1.20B | 150.00M |
| Q3 FY2001 | 31 Jan 2001 | 1.36B | +8.17% | 1.09B | 302.80M |
| Q2 FY2001 | 31 Oct 2000 | 1.36B | +17.31% | 1.01B | 314.10M |
| Q1 FY2001 | 31 Jul 2000 | 1.31B | +18.55% | 993.80M | 289.00M |
| Q4 FY2000 | 30 Apr 2000 | 1.43B | +27.99% | 1.12B | 322.20M |
| Q3 FY2000 | 31 Jan 2000 | 1.26B | +21.17% | 990.90M | 263.20M |
| Q2 FY2000 | 31 Oct 1999 | 1.16B | +59.32% | 968.60M | 257.50M |
| Q1 FY2000 | 31 Jul 1999 | 1.10B | +69.15% | 879.20M | 248.90M |
| Q4 FY1999 | 30 Apr 1999 | 1.12B | +63.36% | 871.40M | 158.10M |
| Q3 FY1999 | 31 Jan 1999 | 1.04B | +64.54% | 760.00M | -34.10M |
| Q2 FY1999 | 31 Oct 1998 | 728.40M | +13.44% | 774.40M | 117.00M |
| Q1 FY1999 | 31 Jul 1998 | 653.20M | +1.07% | 784.70M | 228.50M |
| Q4 FY1998 | 30 Apr 1998 | 685.00M | +6.96% | 547.10M | 160.10M |
| Q3 FY1998 | 31 Jan 1998 | 631.40M | +5.46% | 614.70M | 33.30M |
| Q2 FY1998 | 31 Oct 1997 | 642.10M | +7.34% | 534.30M | 143.50M |
| Q1 FY1998 | 31 Jul 1997 | 646.30M | +7.56% | 520.10M | 146.50M |
| Q4 FY1997 | 30 Apr 1997 | 640.40M | +7.43% | 507.70M | 145.50M |
| Q3 FY1997 | 31 Jan 1997 | 598.70M | +13.13% | 474.40M | 128.70M |
| Q2 FY1997 | 31 Oct 1996 | 598.20M | +15.35% | 478.70M | 128.30M |
| Q1 FY1997 | 31 Jul 1996 | 600.90M | +14.72% | 484.10M | 127.40M |
| Q4 FY1996 | 30 Apr 1996 | 596.10M | +15.37% | 466.40M | 125.40M |
| Q3 FY1996 | 31 Jan 1996 | 529.20M | +27.92% | 412.10M | 109.00M |
| Q2 FY1996 | 31 Oct 1995 | 518.60M | +27.05% | 402.80M | 104.60M |
| Q1 FY1996 | 31 Jul 1995 | 523.80M | +29.72% | 409.60M | 99.70M |
| Q4 FY1995 | 30 Apr 1995 | 516.70M | +31.51% | 389.00M | 87.80M |
| Q3 FY1995 | 31 Jan 1995 | 413.70M | +23.64% | 309.00M | 71.40M |
| Q2 FY1995 | 31 Oct 1994 | 408.20M | +22.91% | 303.10M | 69.70M |
| Q1 FY1995 | 31 Jul 1994 | 403.80M | +21.88% | 307.60M | 65.10M |
| Q4 FY1994 | 30 Apr 1994 | 392.90M | +9.66% | 289.60M | 66.80M |
| Q3 FY1994 | 31 Jan 1994 | 334.60M | +8.57% | 250.20M | 56.90M |
| Q2 FY1994 | 31 Oct 1993 | 332.10M | +0.09% | 249.90M | 56.20M |
| Q1 FY1994 | 31 Jul 1993 | 331.30M | +0.42% | 248.10M | 52.50M |
| Q4 FY1993 | 30 Apr 1993 | 358.30M | +7.37% | 264.80M | 58.00M |
| Q3 FY1993 | 31 Jan 1993 | 308.20M | +2.90% | 226.60M | 47.80M |
| Q2 FY1993 | 31 Oct 1992 | 331.80M | +18.92% | 243.30M | 60.20M |
| Q1 FY1993 | 31 Jul 1992 | 329.90M | +24.63% | 243.10M | 45.60M |
| Q4 FY1992 | 30 Apr 1992 | 333.70M | +18.63% | 256.00M | 47.40M |
| Q3 FY1992 | 31 Jan 1992 | 299.50M | +18.75% | 207.30M | 39.40M |
| Q2 FY1992 | 31 Oct 1991 | 279.00M | +9.58% | 198.60M | 38.50M |
| Q1 FY1992 | 31 Jul 1991 | 264.70M | +17.59% | 192.60M | 36.10M |
| Q4 FY1991 | 30 Apr 1991 | 281.30M | +18.84% | 208.50M | 40.30M |
| Q3 FY1991 | 31 Jan 1991 | 252.20M | +21.60% | 181.80M | 34.20M |
| Q2 FY1991 | 31 Oct 1990 | 254.60M | +26.92% | 181.30M | 28.70M |
| Q1 FY1991 | 31 Jul 1990 | 225.10M | +17.30% | 161.70M | 28.80M |
| Q4 FY1990 | 30 Apr 1990 | 236.70M | +19.61% | 168.20M | 31.00M |
| Q3 FY1990 | 31 Jan 1990 | 207.40M | +11.03% | 150.20M | 27.10M |
| Q2 FY1990 | 31 Oct 1989 | 200.60M | +10.71% | 145.20M | 26.20M |
| Q1 FY1990 | 31 Jul 1989 | 191.90M | +9.16% | 0.00 | 27.10M |
| Q4 FY1989 | 30 Apr 1989 | 197.90M | +4.60% | 0.00 | 25.40M |
| Q3 FY1989 | 31 Jan 1989 | 186.80M | +11.66% | 0.00 | 23.80M |
| Q2 FY1989 | 31 Oct 1988 | 181.20M | +19.05% | 0.00 | 22.70M |
| Q1 FY1989 | 31 Jul 1988 | 175.80M | +21.58% | 0.00 | 25.40M |
| Q4 FY1988 | 30 Apr 1988 | 189.20M | +31.48% | 0.00 | 23.00M |
| Q3 FY1988 | 31 Jan 1988 | 167.30M | +37.36% | 0.00 | 21.60M |
| Q2 FY1988 | 31 Oct 1987 | 152.20M | +26.73% | 0.00 | 21.70M |
| Q1 FY1988 | 31 Jul 1987 | 144.60M | +24.44% | 0.00 | 20.30M |
| Q4 FY1987 | 30 Apr 1987 | 143.90M | +29.52% | 0.00 | 20.00M |
| Q3 FY1987 | 31 Jan 1987 | 121.80M | +21.68% | 0.00 | 18.20M |
| Q2 FY1987 | 31 Oct 1986 | 120.10M | +19.27% | 0.00 | 17.80M |
| Q1 FY1987 | 31 Jul 1986 | 116.20M | — | 0.00 | 17.80M |
| Q4 FY1986 | 30 Apr 1986 | 111.10M | — | 0.00 | 16.00M |
| Q3 FY1986 | 31 Jan 1986 | 100.10M | — | 0.00 | 0.00 |
| Q2 FY1986 | 31 Oct 1985 | 100.70M | — | 0.00 | 14.80M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Medtronic revenue growth by segment
Q1 FY2027 against Q1 FY2026
Cardiac and Vascular Group3.93B
+19.5%
Neuroscience Group2.68B
+10.8%
Medical Surgical2.28B
+9.4%
Diabetes Group843.00M
+16.9%
Medtronic revenue by segment over time
Cardiac and Vascular Group Neuroscience Group Medical Surgical Diabetes Group Restorative Therapies Group Minimally Invasive Therapies Group Neuroscience Portfolio Diabetes Operating Unit Cardiovascular Portfolio Medical Surgical Portfolio
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Medtronic's revenue
Source: Financial Modeling Prep